Conditions of Entry

Preliminary information

Through this award, Biologische Heilmittel Heel GmbH supports health care practitioners who report and aim to publish outstanding clinical cases, which integrate different treatment modalities to provide the best patient-centered care.


The Hans-Heinrich Reckeweg Clinical Case Award is bestowed for excellent clinical case reporting that educates about multitarget treatments.

Biologische Heilmittel Heel GmbH sponsors the Award under the auspices of an international Award Review Committee. The Committee reviews and selects the winners based on predefined criteria.

The winner will receive € 10,000 for the main award, and €5,000 for the runner-up award. In certain circumstances as determined by the international review panel, the awards may also be shared.

Award criteria

The prize will be awarded for unpublished clinical case reports based on the following


1. Excellent clinical case reporting in compliance with the international CARE (CAse REport) guidelines ( that makes it eligible for scientific publication in a peer-reviewed journal.

2. The clinical case report explains in necessary detail the assessment of the patient’s current health status and rationale for the application of the multitarget intervention.

3. The clinical case report should explain how the insights of the presented case contribute to the existing evidence base of observational clinical research.

Who should apply?

Application is open to all licensed healthcare practitioners worldwide (human or veterinary). Directors, managers and all other employees of Biologische Heilmittel Heel GmbH and affiliated companies are not eligible to enter.


In the application each author should fill the provided submission form with the requested information. Go to submission page

Submission acceptance criteria

Upon receipt each submission will be pre-assessed for compliance with acceptance criteria before sending it further to the international Award Review Committee for the peer-review. Only those submissions that:

a) are complete (all sections are filled),

b) raise no ethical concerns (patient consent form is signed and attached),

c) provide author contact information and confirmation of primary authorship

will be considered for the peer-review process. The authors will be notified in the separate e-mail whether their submission was accepted or not.

Award Review Committee

The submitted applications are awarded by an international panel of experts according to the award criteria (see point §3). After closing the submission, the Award Review Committee finalizes the shortlist of potential winners and reaches the decision by Oct 2018.